{"product_id":"spondyloarthritis-research-and-treatment-network-23rd-spartan-annual-meeting-2025","title":"Spondyloarthritis Research and Treatment Network 23rd SPARTAN Annual Meeting 2025","description":"\u003cdiv id=\"comp-kaa36yrs\" class=\"KaEeLN comp-kaa36yrs\"\u003e\r\n\u003cdiv class=\"\" data-mesh-id=\"comp-kaa36yrsinlineContent\" data-testid=\"inline-content\"\u003e\r\n\u003cdiv data-mesh-id=\"comp-kaa36yrsinlineContent-gridContainer\" data-testid=\"mesh-container-content\"\u003e\r\n\u003cdiv id=\"comp-ka9z3j2z\" class=\"HcOXKn SxM0TO QxJLC3 lq2cno comp-ka9z3j2z wixui-rich-text\" data-testid=\"richTextElement\"\u003e\r\n\u003cdiv class=\"prod-title\"\u003e\r\n\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eSpondyloarthritis Research and Treatment Network 23rd SPARTAN Annual Meeting 2025\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Include: 33 videos + 1 pdf, size: 23.32 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: rheumatologists and immunologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eThe Spondyloarthritis Research and Treatment Network 23rd SPARTAN Annual Meeting 2025 provides an in-depth review of the latest advancements in the diagnosis, pathophysiology, and treatment of Spondyloarthritis (SpA). The program covers fundamental mechanisms like HLA-B27, cutting-edge therapies such as CAR-T, evolving imaging guidelines, and critical intersections with conditions like Inflammatory Bowel Disease (IBD).\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"423\"\u003eCourse Date:\u003c\/b\u003e \u003cem\u003eMay 9-10, 2025\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"3\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,0,0\"\u003eAnalyze the pathophysiological mechanisms of Spondyloarthritis, including the roles of HLA-B27, T cells, and spatial gene profiles.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,1,0\"\u003eEvaluate individualized treatment options and the safety of emerging therapies like CAR-T and NSAIDs in adult and pediatric SpA patients.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,2,0\"\u003eApply advanced MRI protocols and physical exam techniques to accurately diagnose and monitor radiographic progression in axial SpA.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,3,0\"\u003eAssess the latest ACR-SPARTAN-SAA clinical guidelines and outcome measures, such as BASDAI, in managing psoriatic arthritis and SpA.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,4,0\"\u003eIdentify the unique clinical manifestations, sex-gender differences, and comorbidities, particularly Inflammatory Bowel Disease, associated with SpA.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\r\nBest for rheumatologists and immunologists who want updates on spondyloarthritis pathophysiology, advanced imaging, and targeted therapies.\r\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\r\n\u003col start=\"1\" data-path-to-node=\"8\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,0,0\"\u003eDay 1 Classification and Clinical Manifestation of SpA- Deep Dive into IBP – Soha Dolatabadi, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,1,0\"\u003eDay 1 Disease Mechanisms in SpA- With and Without HLAB27 – Akihiro Nakamura, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,2,0\"\u003eDay 1 IBD and SpA – Reem Jan, MD, MBBS\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,3,0\"\u003eDay 1 Individualize axSpA Treatment Options a Case Based Discussion- Lianne Gensler, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,4,0\"\u003eDay 1 MRI Workshop- Protocol, Finding, and Mimickers – Dennis Poddubnyy, MD, PhD, MSc\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,5,0\"\u003eDay 1 Sex-Gender differences in Presentation and Manifestations of SpA – Lihi Eder, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,6,0\"\u003eDay 1 Slowing Radiographic Progression in Axial SpA – Marina Magrey, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,7,0\"\u003eDay 1 SpA Physical Exam Workshop – Philip Mease, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,8,0\"\u003eDay 2 Basic Science – Ruth Napier, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,9,0\"\u003eDay 2 CAR-T (non-CD19) – Naoto Hirano, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,10,0\"\u003eDay 2 CLASSIC – Walter Maksymowych, MD, FRCP, FACP, University of Alberta, Alberta\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,11,0\"\u003eDay 2 Clinical Science and Imaging – Jean Liew, MD, MS\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,12,0\"\u003eDay 2 Clinical Trials – Abhijeet Danve, MBBS, MD, FACP\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,13,0\"\u003eDay 2 IBD and SpA – Reem Jan, MD, MBBS\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,14,0\"\u003eDay 2 Neuroimaging of Pain in Ankylosing Spondylitis Karen D. Davis, PhD, FCAHS, FRSC, Professor, Department of Surgery …\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,15,0\"\u003eDay 2 SESSION I- Year in Review Moderators- Nigil Haroon, MD and Mohamed Bittar, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,16,0\"\u003eDay 2 SPARTAN Research Career Achievement and Distinguished Service Award Presentations\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,17,0\"\u003eDay 2 T cells Animal Studies CD4-CD8-MAIT-NK-T – Judith Smith, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,18,0\"\u003eDay 2 T cells AS Patients – Michael Paley, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,19,0\"\u003eDay 3 ACR-SPARTAN-SAA Guidelines – Liron Caplan, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,20,0\"\u003eDay 3 BASDAI and its Components as Outcome Measures for axPsA – Pankti Mehta, MD, MBBS\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,21,0\"\u003eDay 3 BASIS – Sibel Aydin, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,22,0\"\u003eDay 3 Imaging – Denis Poddubnyy, MD, PhD, MSc\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,23,0\"\u003eDay 3 Mapping the PBR of SpA-associated Versus SpA-neutral HLA-B-27 Alleles, Using a High-throughput Genetic Screening …\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,24,0\"\u003eDay 3 MRI neg axSpA does not exist – Lianne Gensler, MD, Atul Deodhar, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,25,0\"\u003eDay 3 New Pediatric SpA Classification Criteria – Pamela Weiss, MD, MSCE\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,26,0\"\u003eDay 3 Safety of Prescription NSAIDs in Adults with IBD- Data from a Large Administrative Claims Cohort – Adam Mayer, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,27,0\"\u003eDay 3 Serum Proteomic Analysis of Cellular Immune Clusters in Psoriatic Arthritis – Steven Dang\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,28,0\"\u003eDay 3 Spatial Gene Profiles for New Bone Formation in Ankylosing Spondylitis – Akihiro Nakamura, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,29,0\"\u003eDay 3 The Deubiquitinase TRABID is a Novel Therapeutic Target in Spondyloarthritis – Archita Srinath\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,30,0\"\u003eDay 3 The Relationship Between HLA-B27 Positivity and Inflammatory Back Pain in the US Population – Mark Hwang, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,31,0\"\u003eGroup Day 1\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,32,0\"\u003eGroup Day 2\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954680991842,"sku":"MED-AMB08084","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Spondyloarthritis-Research-and-Treatment-Network-23rd-SPARTAN-Annual-Meeting-2025.jpg?v=1779382321","url":"https:\/\/meducourse.com\/products\/spondyloarthritis-research-and-treatment-network-23rd-spartan-annual-meeting-2025","provider":"Meducourse","version":"1.0","type":"link"}